MaxCyte, Inc.
MXCT
$2.61
$0.062.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -44.51% | 2.00% | 15.33% | 32.25% | 26.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -44.51% | 2.00% | 15.33% | 32.25% | 26.10% |
| Cost of Revenue | 45.01% | 143.13% | 8.14% | 40.30% | 1.74% |
| Gross Profit | -54.50% | -13.52% | 16.62% | 31.19% | 29.56% |
| SG&A Expenses | -10.50% | 0.62% | 1.11% | 4.88% | 38.60% |
| Depreciation & Amortization | -4.05% | -1.16% | 5.83% | 17.11% | 21.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.12% | 1.19% | 1.27% | 8.56% | 23.92% |
| Operating Income | -59.35% | -0.72% | 8.45% | 6.85% | -19.93% |
| Income Before Tax | -100.78% | -2.72% | 10.82% | 12.46% | -9.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -100.78% | -2.72% | 10.82% | 12.46% | -9.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.78% | -2.72% | 10.82% | 12.46% | -9.74% |
| EBIT | -59.35% | -0.72% | 8.45% | 6.85% | -19.93% |
| EBITDA | -69.35% | -0.90% | 9.63% | 8.61% | -19.95% |
| EPS Basic | -97.25% | -1.10% | 12.16% | 13.52% | -8.07% |
| Normalized Basic EPS | -97.48% | -1.03% | 12.09% | 13.46% | -8.16% |
| EPS Diluted | -97.25% | -1.10% | 12.16% | 13.52% | -8.07% |
| Normalized Diluted EPS | -97.48% | -1.03% | 12.09% | 13.46% | -8.16% |
| Average Basic Shares Outstanding | 1.78% | 1.60% | 1.53% | 1.21% | 1.55% |
| Average Diluted Shares Outstanding | 1.78% | 1.60% | 1.53% | 1.21% | 1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |